Literature DB >> 9791843

Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia.

M A Jabbar1, M I Zuhri-Yafi, J Larrea.   

Abstract

OBJECTIVE: To compare the short and long term effectiveness of fish oil, insulin, and gemfibrozil in a non-diabetic patient with severe hypertriglyceridemia.
METHOD: An adolescent male with hypertriglyceridemia (triglyceride level 4575 mg/dl) and abdominal pain was treated with the goal of immediate reduction and maintenance of triglyceride (TG) level below 1000 mg/dl. Fish oil, insulin and gemfibrozil were administered sequentially, in separate time blocks, for a duration of 3, 6, and 6 months, respectively.
RESULTS: Fish oil took several weeks to lower TG level, and patient compliance during 3 months of therapy was inadequate. Insulin was effective in immediately lowering the TG level, but was unable to maintain the level below 1000 mg/dl. Gemfibrozil was ineffective in achieving the immediate reduction of TG level; however, it was adequate in maintaining the desired level in the long-term and patient compliance was better than with the fish oil.
CONCLUSION: In patients with risk of pancreatitis due to severe hypertriglyceridemia, immediate reduction of the triglyceride level is achievable by using a single dose of regular insulin (0.1 unit/kg, subcutaneous) while long-term maintenance therapy can be provided by gemfibrozil.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9791843     DOI: 10.1080/07315724.1998.10718794

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  20 in total

Review 1.  Metabolic and catheter complications of parenteral nutrition.

Authors:  Marwan S Ghabril; Jamie Aranda-Michel; James S Scolapio
Journal:  Curr Gastroenterol Rep       Date:  2004-08

Review 2.  Severe gestational hypertriglyceridemia: A practical approach for clinicians.

Authors:  Bertha Wong; Teik C Ooi; Erin Keely
Journal:  Obstet Med       Date:  2015-08-21

3.  Rapid reduction of severely elevated serum triglycerides with insulin infusion, gemfibrozil and niacin.

Authors:  Sujani Poonuru; Sumedha R Pathak; Hemender S Vats; Ram D Pathak
Journal:  Clin Med Res       Date:  2010-09-17

4.  Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis.

Authors:  Hakan Alagözlü; Mehmet Cindoruk; Tarkan Karakan; Selahattin Unal
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

5.  Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis.

Authors:  Hakan Alagozlu; Mehmet Cindoruk; Selahattin Unal
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

6.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

7.  Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report.

Authors:  Güven Barış Cansu; Nusret Yılmaz; Hasan Altunbaş; Mustafa Kemal Balcı; Ramazan Sarı
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

Review 8.  Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis.

Authors:  Nils Ewald; Hans-Ulrich Kloer
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

9.  Hypertriglyceridemic pancreatitis in pregnancy: case reports and review of the literature.

Authors:  Kumar Thulasidass; Tahseen A Chowdhury
Journal:  JRSM Short Rep       Date:  2013-07-01

10.  Case Studies in Pediatric Lipid Disorders and Their Management.

Authors:  Ambika P Ashraf; Bhuvana Sunil; Vaneeta Bamba; Emily Breidbart; Preneet Cheema Brar; Stephanie Chung; Anshu Gupta; Aditi Khokhar; Seema Kumar; Marissa Lightbourne; Manmohan K Kamboj; Ryan S Miller; Nivedita Patni; Vandana Raman; Amy S Shah; Don P Wilson; Brenda Kohn
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.